Todd Keiller is the Director of the Technology Transfer Office at the University of Vermont, Caritas St. Elizabeth's Medical Center of Boston, Boston Biomedical Research Institute, and Maine Medical Center. Mr. Keiller offers thirty years of experience in licensing, business development, and marketing. His work in the industrial sector includes ten years in the Science and Medical Products divisions of Corning Glass Works and encompassed a variety of sales, marketing, and business development roles. His fourteen years of academic licensing experience includes the position of Vice President for Ventures at the Brigham and Women's Hospital in Boston.
Mr. Keiller is a founder of six companies, most recently CorAutus (formerly Vascular Genetics, Inc.), a publicly traded gene therapy company; and Tolerance Pharmaceuticals, a diagnostic and therapeutic company recently acquired by Roche and focusing in transplantation and immunosuppression.
Todd Keiller received his MBA from the Tuck School of Business at Dartmouth and an A.B. degree from Dartmouth College.
So I think there is a need for the inventor to retain his or her own counsel if you are going to have a startup, having had inventors on the front page of the globe, inappropriately in my opinion, or most of the time not in the globe because I did have the right counsel at the beginning. And the ri...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login